Overview

Founded in 2011 by scientists from leading global companies driven to build a world-class platform for small molecule and oligonucleotides, development and cGMP manufacturing. Supporting Innovative pharmaceutical companies in fields of small molecules, oligonucleotides and lipids, from route discovery, process development, optimization, to cGMP manufacture of RSMs and APIs.

公司介绍

Helping human health through applying innovative technologies to support development of new pharmaceuticals.

Management Team

Dr. Ye Weiping

Founder, Chairman, CEO;

- Served as principle scientist in GlaxoSmithKline, Won "Excellent Contribution" award for three times

- Served as Outsourcing Manager of Aisa in supply chain department of Pfizer;

- Ph.D. in organic chemistry from National University of Singapore

- 15+ years experiences in pharmaceutical industry;

- Served as the senior scientist(project leader) in GlaxoSmithKline. Leaded process developments for 9 new pharmaceuticals;

- Ph.D. in organic chemistry from Australian National University.

Dr. Andrew Phillis

Co-founder, CBO,

Dr. Zhou Zhangtao

Co-founder, CTO

- 10+ years experiences；

- Good at applying competitive new technologies in API development, technology transfer and manufacturing. Expert of flow chemistry and asymmetric synthesis.

- Served as senior scientist II (project leader) in Lonza for 5 years in CMC study and commercial production businesses;

- Ph.D. in organic chemistry from Nankai University.

Huiqin Liu

Senior VP

- In charge of operation and production;

- Master of Pharmaceutical Engineering from Tianjin University.

Mission